A Study to Compare Two Formulations of LY3209590 in Healthy Participants

NCT05914688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3209590 (Formulation 1)
DRUG: LY3209590 (Formulation 2)

Sponsor

Eli Lilly and Company